Kosaku Nitta Selected Research

Steroids

1/2022	Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
1/2022	A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy.
10/2021	Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
1/2021	Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan.
11/2020	Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.
4/2020	The impact of tonsillectomy combined with steroid pulse therapy in patients with advanced IgA nephropathy and impaired renal function.
10/2018	Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease.
9/2018	Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series.
8/2018	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
1/2018	Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kosaku Nitta Research Topics

Disease

75	Proteinuria 01/2022 - 05/2002
49	Chronic Renal Insufficiency 01/2022 - 12/2007
41	IGA Glomerulonephritis (IGA Nephropathy) 09/2022 - 03/2002
34	Glomerulonephritis 01/2022 - 03/2003
30	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 01/2002
28	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 07/2002
25	Vascular Calcification 01/2018 - 10/2002
19	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 01/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2004
16	Hematuria 10/2021 - 01/2002
15	Autosomal Dominant Polycystic Kidney (ADPKD) 06/2022 - 06/2011
15	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 01/2002
14	Anemia 01/2021 - 08/2007
14	Hypertension (High Blood Pressure) 06/2020 - 01/2004
14	Fibrosis (Cirrhosis) 12/2019 - 01/2003
13	Infections 01/2022 - 01/2007
13	Inflammation (Inflammations) 01/2019 - 01/2002
12	Kidney Diseases (Kidney Disease) 09/2022 - 10/2011
11	Disease Progression 06/2022 - 01/2002
10	Lupus Nephritis 01/2022 - 01/2009
10	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2020 - 01/2008
10	Albuminuria 01/2019 - 12/2010
9	Renal Insufficiency (Renal Failure) 03/2022 - 01/2008
9	Diabetes Mellitus 03/2022 - 01/2008
9	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2022 - 08/2004
7	Sclerosis 01/2022 - 01/2003
6	Fever (Fevers) 01/2022 - 01/2007
6	Vasculitis (Vasculitides) 01/2022 - 08/2009
6	Hyperuricemia 01/2022 - 07/2014
6	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 01/2005
6	Atherosclerosis 05/2016 - 02/2010
5	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022 - 09/2004
5	Nephritis 01/2022 - 01/2002
5	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 07/2003
5	Interstitial Nephritis (Tubulointerstitial Nephritis) 11/2020 - 08/2009
5	Hemorrhage 08/2017 - 01/2003
5	Dyslipidemias (Dyslipidemia) 08/2012 - 01/2008
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 02/2008
4	Microscopic Polyangiitis 01/2022 - 01/2008
4	Cysts 01/2022 - 11/2018
4	Bone Diseases (Bone Disease) 03/2021 - 04/2013
4	Amyloidosis 01/2021 - 05/2009
4	Malnutrition (Nutritional Deficiencies) 10/2020 - 01/2015
4	Neoplasms (Cancer) 10/2020 - 01/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2018 - 01/2005

Drug/Important Bio-Agent (IBA)

43	SteroidsIBA 01/2022 - 01/2002
32	CreatinineIBA 01/2022 - 05/2002
31	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
20	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2002
20	Rituximab (Mabthera)FDA Link 01/2020 - 01/2009
18	Prednisolone (Predate)FDA LinkGeneric 10/2021 - 01/2002
15	Immunoglobulin A (IgA)IBA 09/2022 - 07/2003
15	Immunoglobulin G (IgG)IBA 11/2020 - 06/2003
14	AlbuminsIBA 10/2021 - 01/2010
13	Hemoglobins (Hemoglobin)IBA 01/2022 - 08/2007
13	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 07/2003
11	Uric Acid (Urate)IBA 01/2022 - 01/2008
11	Pharmaceutical PreparationsIBA 05/2021 - 01/2010
10	Parathyroid Hormone (Parathormone)IBA 01/2022 - 12/2011
10	Serum AlbuminIBA 01/2022 - 08/2007
10	Phosphates (Orthophosphate)IBA 01/2022 - 08/2007
10	MineralsIBA 03/2021 - 08/2007
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2003
10	Vitamin D FDA LinkGeneric 11/2019 - 01/2010
8	C-Reactive ProteinIBA 01/2022 - 01/2007
8	Fibroblast Growth Factor-23IBA 01/2022 - 12/2010
8	Angiotensin Receptor AntagonistsIBA 01/2021 - 09/2008
7	Indicators and Reagents (Reagents)IBA 09/2022 - 02/2008
7	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2002
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 12/2007
7	IronIBA 01/2019 - 01/2012
6	CholesterolIBA 11/2021 - 01/2007
6	Immunoglobulin M (IgM)IBA 01/2021 - 07/2003
6	Tacrolimus (Prograf)FDA LinkGeneric 01/2020 - 01/2009
6	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 02/2008
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 01/2008
5	Tolvaptan FDA Link 06/2022 - 01/2018
5	Cinacalcet (Sensipar)FDA Link 01/2022 - 02/2010
5	AntibodiesIBA 03/2020 - 09/2002
5	Antihypertensive Agents (Antihypertensives)IBA 07/2019 - 01/2008
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2002
5	CalciumIBA 01/2018 - 12/2011
5	Triglycerides (Triacylglycerol)IBA 09/2013 - 01/2007
5	AdiponectinIBA 06/2013 - 01/2007
4	oxidized low density lipoproteinIBA 11/2020 - 02/2010
4	HDL CholesterolIBA 09/2019 - 06/2012
4	Dialysis SolutionsIBA 11/2018 - 04/2007
4	Eicosapentaenoic AcidIBA 01/2018 - 12/2010
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018 - 07/2009

Therapy/Procedure

82	Therapeutics 03/2022 - 01/2002
74	Renal Dialysis (Hemodialysis) 01/2022 - 01/2002
13	Transplantation 01/2020 - 01/2005
13	Kidney Transplantation 01/2019 - 01/2005
11	Tonsillectomy 10/2021 - 01/2011
6	Plasma Exchange 07/2018 - 01/2007
5	Peritoneal Dialysis 01/2022 - 01/2003
4	Parathyroidectomy 01/2022 - 04/2011
4	Plasmapheresis 01/2020 - 09/2002
4	Drug Therapy (Chemotherapy) 11/2019 - 01/2011
4	Nephrectomy 01/2019 - 04/2011